These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34822224)

  • 21. Leishmania treatment and prevention: Natural and synthesized drugs.
    Bekhit AA; El-Agroudy E; Helmy A; Ibrahim TM; Shavandi A; Bekhit AEA
    Eur J Med Chem; 2018 Dec; 160():229-244. PubMed ID: 30342363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham.
    de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC
    Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational approaches for drug designing against leishmaniasis.
    Shukla AK; Singh BK; Patra S; Dubey VK
    Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis.
    Salem MM; Werbovetz KA
    Curr Med Chem; 2006; 13(21):2571-98. PubMed ID: 17017912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemistry, cytotoxicity and antileishmanial activity of the essential oil from Piper auritum.
    Monzote L; García M; Montalvo AM; Scull R; Miranda M
    Mem Inst Oswaldo Cruz; 2010 Mar; 105(2):168-73. PubMed ID: 20428676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colombian Contributions Fighting Leishmaniasis: A Systematic Review on Antileishmanials Combined with Chemoinformatics Analysis.
    Sánchez-Suárez J; Bernal FA; Coy-Barrera E
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promising natural products for the treatment of cutaneous leishmaniasis: A review of in vitro and in vivo studies.
    Afonso RC; Yien RMK; de Siqueira LBO; Simas NK; Dos Santos Matos AP; Ricci-Júnior E
    Exp Parasitol; 2023 Aug; 251():108554. PubMed ID: 37268108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marine Algae as Source of Novel Antileishmanial Drugs: A Review.
    Tchokouaha Yamthe LR; Appiah-Opong R; Tsouh Fokou PV; Tsabang N; Fekam Boyom F; Nyarko AK; Wilson MD
    Mar Drugs; 2017 Oct; 15(11):. PubMed ID: 29109372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
    Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
    Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review.
    Passero LFD; Cruz LA; Santos-Gomes G; Rodrigues E; Laurenti MD; Lago JHG
    Curr Top Med Chem; 2018; 18(15):1275-1286. PubMed ID: 30277153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptides to Tackle Leishmaniasis: Current Status and Future Directions.
    Robles-Loaiza AA; Pinos-Tamayo EA; Mendes B; Teixeira C; Alves C; Gomes P; Almeida JR
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.
    Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
    Curr Med Chem; 2012; 19(14):2128-75. PubMed ID: 22414103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eugenia piauhiensis Vellaff. essential oil and γ-elemene its major constituent exhibit antileishmanial activity, promoting cell membrane damage and in vitro immunomodulation.
    Nunes TAL; Costa LH; De Sousa JMS; De Souza VMR; Rodrigues RRL; Val MDCA; Pereira ACTDC; Ferreira GP; Da Silva MV; Da Costa JMAR; Véras LMC; Diniz RC; Rodrigues KADF
    Chem Biol Interact; 2021 Apr; 339():109429. PubMed ID: 33713644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.
    Ogungbe IV; Setzer WN
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27775577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level.
    González-Matos M; Aguado ME; Izquierdo M; Monzote L; González-Bacerio J
    Exp Parasitol; 2024 May; 260():108747. PubMed ID: 38518969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antileishmanial activity of the essential oil from Bixa orellana.
    Monzote L; García M; Scull R; Cuellar A; Setzer WN
    Phytother Res; 2014 May; 28(5):753-8. PubMed ID: 23983115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of natural products with antileishmanial activity.
    Rocha LG; Almeida JR; Macêdo RO; Barbosa-Filho JM
    Phytomedicine; 2005 Jun; 12(6-7):514-35. PubMed ID: 16008131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-Vitro Evaluation of 52 Commercially-Available Essential Oils Against
    Monzote L; Herrera I; Satyal P; Setzer WN
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fruitful decade for antileishmanial compounds from 2002 to late 2011.
    Hussain H; Al-Harrasi A; Al-Rawahi A; Green IR; Gibbons S
    Chem Rev; 2014 Oct; 114(20):10369-428. PubMed ID: 25253511
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening natural products database for identification of potential antileishmanial chemotherapeutic agents.
    Venkatesan SK; Saudagar P; Shukla AK; Dubey VK
    Interdiscip Sci; 2011 Sep; 3(3):217-31. PubMed ID: 21956744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.